Drug Type Small molecule drug |
Synonyms NBM BMX softgel capsules, NBM-BMX |
Target |
Mechanism HDAC8 inhibitors(Histone deacetylase 8 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H27NO5 |
InChIKeySOWOYQPLOHLYEY-NTEUORMPSA-N |
CAS Registry1246952-34-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
FGF19 positive Solid Tumors | Phase 2 | TW | - | 11 Aug 2023 |
Glioblastoma | Phase 2 | TW | - | 11 Aug 2023 |
Neoplasms | Phase 2 | CN | 24 Aug 2022 | |
Alzheimer Disease | Phase 1 | CN | 24 Aug 2022 | |
Advanced cancer | Phase 1 | US | 16 Oct 2018 | |
Advanced Malignant Solid Neoplasm | Phase 1 | US | 16 Oct 2018 |